Minsi Zhang

Minsi Zhang practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Minsi Zhang's NPI, 1366837205, was assigned on March 30, 2015. Minsi Zhang graduated from Duke University School Of Medicine in 2015. Minsi Zhang holds New York license 285895-1.

Minsi Zhang's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Minsi Zhang's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Monmouth. Dmand AI also links Minsi Zhang to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Minsi Zhang practices. Vendor and product names are available with a free account.

Radiation oncology is Minsi Zhang's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Minsi Zhang is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Minsi Zhang's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists bone cancer radiation, cancer radiation-upper GI and lung cancer radiation among the conditions Minsi Zhang treats.

CMS data shows 274 Medicare services from Minsi Zhang across 6 procedure codes in 2024, for 165 Medicare patients. Medicare paid $12,393 for them.

CMS counts 165 Medicare patients who saw Minsi Zhang in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Minsi Zhang's median patient age at 69, with 41% women.

In 2018, Minsi Zhang wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $353 in total drug cost. In 2017, CMS named 116 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Minsi Zhang for performance year 2024, reported as part of a group. Minsi Zhang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Minsi Zhang as offering telehealth.

Dmand AI links 17 papers to Minsi Zhang, published from 2012 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Mice, Transgenic, Mice, Inbred C57BL and Sarcoma. Minsi Zhang has published most often in Adv Radiat Oncol. Minsi Zhang's most frequent co-authors are Kaled M. Alektiar, MD, Corinne M. Linardic, MD, PhD and Abraham Jing-Ching Wu, MD.

Minsi Zhang graduated from Duke University School Of Medicine in 2015.

Minsi Zhang is in network with 3 carriers, including Aetna, CMS Medicare and NY State Medicaid. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.